Our Strategy

Our Strategy is to focus on the following key areas:
1. Multi Product Fill and Finish Vaccine Manufacturing
2. Drug Substance Vaccine Manufacturing
3. Manufacturing of other biopharmaceuticals viz: Monoclonal Antibodies (MABs), Blood Plasma, Gene therapy, Biosimilars
4. Research and Development.